Author:
Huq Fazlul,Yu Jun Qing,Beale Philip
Reference18 articles.
1. Farrell N. Platinum anti-cancer drugs. In: Sessler JA, Doctorow SE, McMurry TJ, and Lippard SJ, eds. From Laboratory to Clinic. ACS Symposium Series 903. Medicinal Inorganic Chemistry, 2005:62–79.
2. Farrell N, Kelland LR, Roberts JD, Van Beusichem M. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. Cancer Res 1992;52:5065–72.
3. Farrell N. Polynuclear platinum drugs. Met Ions Biol Syst 2004;41:252–96.
4. Farrell N. Polynuclear charged platinum as a new class of anticancer agents: toward a new paradigm. In: Kelland LR, Farrell NP, eds. Platinum-Based Drugs in Cancer Therapy. Totowa, New Jersey: Humana Press, 2000:321–38.
5. Huq F, Daghriri H, Yu JQ, Beale P, Fisher K. Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH3)Cl2 where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-α)pyridine. Eur J Med Chem 2004;39:691–7.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献